NewsPrivate Equity20/10/2026
Solabia unveils strategic repositioning toward cosmetics and nutraceuticals
Astorg →Astorg announced Solabia’s strategic repositioning toward cosmetics, nutrition and life sciences, with a planned divestment of its microbiology diagnostics division. Muriel Koch was appointed President and CEO effective 29 October 2026.